![Mark Alvino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Alvino
Direktor/Vorstandsmitglied bei
ABEONA THERAPEUTICS INC.
Vermögen: 445 436 $ am 31.05.2026
Profil
Mark J.
Alvino is the founder of Bridge Back Foundation.
Current jobs include Independent Director at Abeona Therapeutics, Inc. since 2021, Director-Business Development at Navitas Pharma, Inc., Director at PainQx, Inc., and President at Hudson Square Capital LLC since 2014.
Former jobs include Director at MacroChem Corp.
in 2009, Independent Director at Abeona Therapeutics, Inc. from 2011 to 2020, Managing Director at SCO Capital Partners LLC from 2002 to 2007, Managing Director at Griffin Securities, Inc. from 2007 to 2013, Managing Director at SCO Financial Group LLC from 2002 to 2007, Vice President-Investor Relations at Allen & Caron, Inc., and Senior VP-Investor & Corporate Communications at Feinstein Kean Healthcare.
Education includes undergraduate degrees from George Washington University and Moravian College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.05.2026 | 77’065 ( 0.14% ) | 445 436 $ | 31.05.2026 |
Aktive Positionen von Mark Alvino
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 25.03.2021 |
Navitas Pharma, Inc.
 Navitas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Hudson Square Capital LLC | Präsident | 01.10.2014 |
Bridge Back Foundation | Vorstandsvorsitzender | - |
PainQx, Inc.
 PainQx, Inc. Packaged SoftwareTechnology Services Develops diagnostic and healthcare software | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark Alvino
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 15.04.2020 |
Griffin Securities, Inc.
 Griffin Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.01.2013 |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 01.02.2009 |
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance SCO invests in value-oriented, micro-cap life sciences companies. They also structure and execute private placement financings. SCO is typically the lead investor in PIPE transactions and then acts as placement agent to complete the financing round. They may call on co-investors to raise additional funds in both initial and future financings. SCO also serves as strategic advisors on mergers and acquisitions and corporate partnerships. | Private Equity Investor | 30.09.2007 |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Mark Alvino
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
SCO Capital Partners LLC
SCO Capital Partners LLC Investment ManagersFinance SCO invests in value-oriented, micro-cap life sciences companies. They also structure and execute private placement financings. SCO is typically the lead investor in PIPE transactions and then acts as placement agent to complete the financing round. They may call on co-investors to raise additional funds in both initial and future financings. SCO also serves as strategic advisors on mergers and acquisitions and corporate partnerships. | Finance |
Navitas Pharma, Inc.
Navitas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Griffin Securities, Inc.
Griffin Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance Operates a full service merchant bank | Finance |
Allen & Caron, Inc.
 Allen & Caron, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and media relations services | Commercial Services |
Moravian College
 Moravian College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Feinstein Kean Healthcare
 Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Provides strategic communications consulting services | Commercial Services |
PainQx, Inc.
PainQx, Inc. Packaged SoftwareTechnology Services Develops diagnostic and healthcare software | Technology Services |
Hudson Square Capital LLC | |
Bridge Back Foundation |
